Stock 460 SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Sihuan Pharmaceutical Holdings Group Ltd.

Equities

460

BMG8162K1137

Pharmaceuticals

Delayed Hong Kong S.E.
Other stock markets
 11:29:23 2024-04-25 pm EDT 		5-day change 1st Jan Change
0.55 HKD +1.85% Intraday chart for Sihuan Pharmaceutical Holdings Group Ltd. +7.84% -15.38%
Apr. 25 Sihuan Pharma Unit Wins Bid to Supply Insulin Products to Chinese Government MT
Mar. 29 Sihuan Pharmaceutical Narrows 2023 Loss on Absence of Asset, Investment Impairments MT

Business Summary

Sihuan Pharmaceutical Holdings Group Ltd is a holding company mainly engaged in pharmaceutical manufacturing business. The Company operates three segments. Medical Aesthetic Products segment includes the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetics comprehensive solutions. Innovative Medicine and Other Medicine segment is engaged in the research and development of innovative drugs in the fields of digestion, oncology, non-alcoholic hepatitis, diabetes and complications. The Company also operates Generic Medicine segment.

Number of employees: 2,872

Sales per Business

HKD in Million2021Weight2022Weight Delta
Generic Medicine
90.3 %
3,131 78.9 % 2,291 90.3 % -26.82%
Medical Aesthetic Products
6.9 %
481 12.1 % 174 6.9 % -63.78%
Innovative Medicine and Other Medicine
2.8 %
355 8.9 % 71 2.8 % -80.02%

Sales per region

HKD in Million2021Weight2022Weight Delta
China
99.3 %
3,967 100.0 % 2,520 99.3 % -36.48%
United States
0.7 %
-- 17 0.7 % -

Managers

Managers TitleAgeSince
Wei Cheng Guo FOU
 Founder 60 00-12-31
Gui Li Miao DFI
 Director of Finance/CFO 50 -
Zhong Xin Jia COO
 Chief Operating Officer 65 06-12-31
Jiong Long Zhang CIO
 Chief Investment Officer 62 06-05-17
Yan Ling Chen BRD
 Director/Board Member 46 06-02-28
Kin Wai Li SEC
 Corporate Secretary 35 22-10-16
Bo Xu SAM
 Sales & Marketing 49 15-12-31

Members of the board

Members of the board TitleAgeSince
Feng Sheng Che FOU
 Founder 63 00-12-31
Wei Cheng Guo FOU
 Founder 60 00-12-31
Jiong Long Zhang CIO
 Chief Investment Officer 62 06-05-17
Xun Zhu BRD
 Director/Board Member 66 14-02-19
Wah Kwong Tsang BRD
 Director/Board Member 71 13-09-03
Yan Ling Chen BRD
 Director/Board Member 46 06-02-28
Guan Wang BRD
 Director/Board Member 43 23-03-31
Gui Li Miao DFI
 Director of Finance/CFO 50 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 9,329,999,000 4,195,873,502 ( 44.97 %) 0 44.97 %

Shareholders

NameEquities%Valuation
Feng Sheng Che
36.31 %
3,388,040,891 36.31 % 229 M $
Wei Cheng Guo
11.92 %
1,112,234,399 11.92 % 75 M $
Xian Hui Meng
4.044 %
377,267,528 4.044 % 26 M $
Jiong Long Zhang
2.739 %
255,582,886 2.739 % 17 M $
Bosera Asset Management Co., Ltd.
0.3508 %
32,734,000 0.3508 % 2 M $
Penghua Fund Management Co., Ltd.
0.2068 %
19,290,000 0.2068 % 1 M $
Hamon Asian Advisors Ltd.
0.0998 %
9,314,000 0.0998 % 630 744 $
China Asset Management Co., Ltd.
0.0935 %
8,723,000 0.0935 % 590 722 $
E Fund Asset Management Co. Ltd.
0.0573 %
5,345,000 0.0573 % 361 963 $
Yan Ling Chen
0.0429 %
4,000,000 0.0429 % 270 880 $

Company contact information

Sihuan Pharmaceutical Holdings Group Ltd.

22nd floor, Building 4 Zhubang 2000 Business Centre

100025, Beijing

+852 3628 3911

http://www.sihuanpharm.com
address Sihuan Pharmaceutical Holdings Group Ltd.(460)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.54
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. Stock Sihuan Pharmaceutical Holdings Group Ltd.
-16.92% 628M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+24.17% 562B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.90% 322B
ABBVIE INC. Stock AbbVie Inc.
+7.95% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.45% 219B
NOVARTIS AG Stock Novartis AG
+6.04% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-10.51% 196B
PFIZER, INC. Stock Pfizer, Inc.
-12.26% 149B
AMGEN INC. Stock Amgen Inc.
-6.47% 146B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 460 Stock
  4. Company Sihuan Pharmaceutical Holdings Group Ltd.